Related Experiment Video
Updated: May 5, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Spatial Dosimetric-Based Prediction of Long-Term Urinary Toxicity After Permanent Prostate Brachytherapy
Chaoqiong Ma1, Ying Hou1, Rajeev Badkul1
1Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
A machine learning model accurately predicts long-term urinary toxicity after low-dose-rate (LDR) prostate brachytherapy using patient symptoms and spatial dose distribution. This helps identify high-risk patients for better treatment planning and outcomes.
Area of Science:
- Radiation oncology
- Medical physics
- Urology
Background:
- Urinary toxicity is a common side effect of low-dose-rate (LDR) prostate brachytherapy.
- Predicting long-term toxicity is crucial for improving patient outcomes and treatment planning.
Purpose of the Study:
- To explore the correlation between spatial dose distribution and post-implant urinary toxicity.
- To develop a predictive model for long-term urinary toxicity in prostate LDR patients.
Main Methods:
- Eighty-five prostate LDR patients with over 12-month follow-up were analyzed.
- Patient-reported urinary toxicity was assessed using the International Prostate Symptom Score (IPSS) questionnaire.
- A machine learning model integrated baseline IPSS and dosimetric features (DVHs) to predict toxicity.
Main Results:
- 48% of patients experienced long-term urinary toxicity.
- The ML model identified baseline IPSS and six dosimetric features (posterior prostate subzones) as key predictors.
- The model achieved a high predictive performance with an AUC of 0.81.
Conclusions:
- Machine learning model effectively predicts long-term urinary toxicity after prostate LDR.
- Integrating spatial dose distribution and baseline symptoms aids in patient risk stratification.
- This approach can guide preventative measures and optimize follow-up care.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022